Sponsors (30)
Official title: To protect an individuals ability to access medicines approved by the Food and Drug Administration to protect a health care providers ability to provide such medicines, and information related to such medicines.
Introduced July 17, 2025 by Deborah K. Ross · Last progress July 17, 2025
The bill greatly expands nationwide access to FDA‑approved medicines and protects providers and facilities from state restrictions, at the cost of curtailing state regulatory flexibility and raising litigation, safety, federalism, and potential fiscal concerns.
Patients (including those with chronic conditions, seniors, and uninsured individuals) can obtain FDA‑approved medicines nationwide — state or local bans cannot bar access — improving treatment availability across the country.
Health care providers (doctors, nurses, pharmacists, clinics and hospitals) are protected in prescribing, discussing, referring for, and facilitating access to FDA‑approved medicines, reducing legal uncertainty for clinicians and enabling more straightforward care delivery.
The law creates enforceable legal tools (private suits with fee‑shifting for prevailing plaintiffs and U.S. Attorney General enforcement) enabling patients and providers to challenge unlawful state restrictions and obtain injunctions more quickly.
State and local governments lose or have significantly curtailed authority to regulate or restrict certain medicines and delivery models (including age limits, dispensing controls, or location‑based restrictions), reducing local public‑health flexibility.
The Act substantially increases litigation risk and legal costs for states, localities, payers, and providers as parties contest whether restrictions meet heightened evidentiary standards or are preempted — creating administrative burdens and expense.
Limiting state safety‑based restrictions may raise public‑health and misuse risks (e.g., for children or vulnerable populations) because states will have less leeway to impose targeted safeguards.
Based on analysis of 8 sections of legislative text.
Creates a federal right to obtain and provide FDA‑approved medicines and preempts laws or rules that prohibit, single out, or impede access to those medicines.
Creates a federal statutory right for individuals to obtain FDA‑approved drugs and for health care providers to prescribe, dispense, refer, and provide information about FDA‑approved medicines without government coercion or special restrictions. The law preempts state or federal rules that prohibit, restrict, single out, or otherwise impede access to FDA‑approved medicines and creates broad civil enforcement by the Attorney General and private parties with fee-shifting and equitable relief.